RFI RAIN Final.pdf

Department of Veterans Affairs Request for Information

Radiopharmaceutical/Radioactive Materials Inventory for Nuclear Medicine (RAIN) November 14, 2025

This is a Request for Information (RFI) only. Do not submit a proposal. This RFI is for planning purposes only and shall not be considered a Request for Proposal. Additionally, there is no obligation on the part of the Government to acquire any products or services described in this RFI.

Your response to this RFI will be treated only as information for the Government to consider. You will not be entitled to payment for direct or indirect costs that you incur in responding to this RFI.

This request does not constitute a solicitation for proposals or the authority to enter into negotiations to award a contract. No funds have been authorized, appropriated or received for this effort. The information provided may be used by the VA in developing its acquisition strategy.

Interested parties are responsible for adequately marking proprietary, restricted or competition-sensitive information contained in their response. The Government does not intend to pay for the information submitted in response to this RFI.

1. INTRODUCTION

It is requested that all contractors interested in participating in this effort please note their interest and provide indication of their respective capabilities to perform the effort for the Radiopharmaceutical Inventory for Nuclear Medicine System Modernization. See draft PWS below for details.

Please provide your response no later than November 25,2025, 1:00pm Eastern Time.

Be advised that set-aside decisions may be made based on the information provided in response to this RFI. Responses should be as complete and informative as possible.

3. RESPONSES

Please submit a capability statement describing your company’s ability to meet the overall requirement described and responses to the questions below. The capability statement shall be limited to 20 pages. The results of the estimated pricing and technical capabilities shall be used to inform VA’s acquisition strategy.

Provide a summary of your technical approach for meeting the requirements for the Radiopharmaceutical Inventory for Nuclear Medicine System specific to the following:

1. Provide an overview of your solution including product brochures and technical requirements.

2. How does your solution meet VA’s Radiopharmaceutical Inventory for Nuclear Medicine System needs as described above? How does your solution enhance patient and staff safety, quality control, threshold dose levels, and adherence NRC and other regulatory requirements listed above?

3. How can your solution improve security and compliance for VA's radiopharmaceutical and radioactive materials environment?

4. Describe any foreseen complications, limitations to support, or integration with the proposed solution.

5. Provide an estimated timeline for Migration and Implementation Support Services to fully integrate the dose tracking system across VA facilities.

a) Describe your plan for migrating data from existing competitor products within VA as well as from existing instances of your solution on disparate servers throughout VHA to potentially shared servers.

b) Describe your plan for migrating data from this solution to a potential new solution by a competitor vendor in the future.

6. For commercial offerings, including software and managed services, please estimate the value to the government of implementing your solution.

7. Provide at least two references for previous implementation efforts of similar scope and scale.

8. Is your solution capable of providing a VA enterprise level deployment that allows restriction to see only users at your local station or Veteran Integrated Service Network (VISN) while also allowing national level access for auditing and reports?

a) Do you recommend local, VISN or VHA wide server deployment? Are there any limitations for any deployment strategies? Any benefits? Please describe.

b) If we have a national contract, how do you handle version control? Do you have a policy to continuously update your software to stay at the most current version, to include operating systems?

c) For a national deployment, are there any technical issues if sites are not on the same version?

9. Does your product integrate to both VISTA/CPRS and Oracle Health Millenium? If so, which VA sites, what data integrates, and how (ex: HL7, etc.)? Do you have an actual interface or is the plan to use an HL7 broker?

a) Describe what information you are able to pull and push via HL7 to the EHR?

b) What HL7 message content does your system accept and utilize?

c) Provide an example HL7 message.

10. Does your solution integrate with 3rd party radio-pharmacies? If so, which ones? Is this integration live at any VA sites? What information is sent back and forth between the VA and the radio-pharmacy?

a) Are you able to manage dosing requests and supply chain requests from multiple radio-pharmacies or your capacity limited to only one?

11. Provide a cost breakdown for the proposed solution. Provide details on how you would propose breaking out the line items for this solution. What types of purchasing options do you offer. For pricing, please include itemized costs for initial deployment and ongoing service/licensing/support fees.

12. What are your resources for system administration? What type of ongoing contract do you recommend? Is there any mandatory maintenance/licensing contract required for your solution?

13. Is there a process for local Nuclear Medicine staff to perform QA/QC on the data and update if necessary (wrong patient identified, etc.)? Does the system provide an audit trail for data correction?

14. Provide samples of standard reports and dashboards.

15. Does your solution have any PET Infusion System interfaces to pull data/reports from injectors such as Intego, etc.? If so, please describe how this works. Do you have this in place at any VA Medical Centers? If so, which ones?

16. Does your system have the capability of documenting written directives, documentation of dose delivered, and documentation of adverse events?

17. Does your company have an existing MOU-ISA and/or BAA with the VA? If not, how do you propose to support remote support? What is your remote service policy? Are there different levels of support? For example, end user phone support, technical support, on site support, etc.

18. Does your system have any integration with Clinical Dictation Systems?

19. Provide examples of the types of reports your system allows.

4. SUBMITTAL INFORMATION

All responsible sources may submit a response in accordance with the information below.

NO MARKETING MATERIALS ARE ALLOWED AS PART OF THIS REQUEST FOR INFORMATION.

Submit your response via email to the Contract Specialist at LeanneKjesbu@va.gov and the Contracting Officer at Joseph.Jones6@va.gov by the time and date indicated herein.

A. Interested Contractors shall at a minimum, provide the following information in the submission:

• Name of Company:

• Address:

• Point of Contact:

• Phone Number:

• Email address:

• Company Business Size and Status:

o For VOSB and SDVOSBs, proof of verification in the Small Business Administration (SBA) VetCert Database.

o For firms who are not SBA VetCert verified, please provide VOSB and/or SDVOSB firms you are working with.

• NAICS code(s):

• System for Award Management (SAM) Unique Entity Identifier (UEI):

• General Services Administration (GSA)/ NASA Solutions for Enterprise-Wide Procurement (SEWP) Contract (as applicable):

• Authorized Distributor Letter:

5. POST RFI PHASE

VA envisions that once RFI responses are reviewed, select responders may be invited to provide a face-to-face or telephonic briefing to VA personnel to answer additional questions with respect to the response given. VA retains sole discretion of whether any post-RFI briefings are warranted, and which industry partners may be invited to provide additional market research information.

OFFERORS ARE ADVISED THAT THIS REQUIREMENT MAY BE DELAYED, CANCELED, OR

REVISED AT ANY TIME.